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ABSTRACT
In themucosa, the immune pathways discriminating be-
tween colonizing and invasiveCandida, thus inducing toler-
ance or inflammation, are poorly understood. Th17 re-
sponses induced byCandida albicans hyphae are central
for the activation of mucosal antifungal immunity. An essen-
tial step for the discrimination between yeasts and hyphae
and induction of Th17 responses is the activation of the in-
flammasome byC. albicans hyphae and the subsequent
release of active IL-1 in macrophages. Inflammasome acti-
vation in macrophages results from differences in cell-wall
architecture between yeasts and hyphae and is partly me-
diated by the dectin-1/Syk pathway. These results define
the dectin-1/inflammasome pathway as themechanism
that enables the host immune system tomount a protective
Th17 response and distinguish between colonization and
tissue invasion byC. albicans. J. Leukoc. Biol. 90:
357–366; 2011.
Introduction
Candida albicans is a common fungal microorganism that colo-
nizes the mucosa and skin. Approximately one-third of individu-
als is colonized with C. albicans at any given time. Despite this, C.
albicans does not normally invade host tissues unless the mucosal
or skin barrier is breached, or the immune system is compro-
mised, leading to mucosal or even disseminated Candida infec-
tion [1]. Recently, Moyes and colleagues [2] have described the
differential pathways of activation of epithelial cells by C. albicans
yeasts and hyphae that are likely to play an important role in the
response to mucosal invasion. However, the mechanism enabling
discrimination between colonizing and invading Candida cells by
the immune system is practically unknown. The presence of colo-
nizing Candida on the mucosa does not induce a strong inflam-
matory reaction, but the immune system is triggered as a conse-
quence of tissue invasion. This implies that mucosal macrophages
and/or DCs, which survey the luminal flora and other mucosal sur-
faces, have evolved tailored signaling-sensing mechanisms that dis-
criminate between colonizing and invading forms of the fungus.
However, the nature of these mechanisms, which are crucial for host
defense and immune tolerance of the mucosa, has yet to be identi-
fied.
The Th17 response has been reported to be crucial for anti-Can-
dida host defense, principally resulting in the recruitment of neutro-
phils [3]. Consequently, IL-17 knockout mice are highly susceptible
to disseminated and mucosal candidiasis [4]. It has been also sug-
gested that IL-17 is impaired in patients with mucosal fungal infec-
tions [5, 6], reinforcing the role of Th17 for anti-Candida host de-
fenses. IL-1 has been shown to be essential for Th17 differentiation
[7]. The production of bioactive IL-1 is achieved via enzymatic
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cleavage of the procytokine form by active caspase-1, which is strictly
regulated by a protein complex called the inflammasome [8, 9].
Among the known inflammasomes, Nlrp3 inflammasome has been
suggested to be responsible for anti-C. albicans defense [10, 11].
In the present study, we aimed to identify the mechanisms
that help macrophages to discriminate between benign coloni-
zation and potentially destructive, invasive phases of the host
interaction with C. albicans. By comparing WT and mutant
strains of C. albicans, which are unable to germinate and form
hyphae, we demonstrate that a vital discriminative factor for
inducing protective mucosal responses is the morphological
transition from yeast to hyphae. In contrast to yeasts that do
not activate the inflammasome, C. albicans hyphae were recog-
nized by macrophages and induced inflammasome activation,
leading to IL-1 production by dectin-1-dependent and -inde-
pendent pathways. This was followed by Th17 differentiation
of naive Th cells with IL-17 and IL-22 production.
MATERIALS AND METHODS
Reagents
The irreversible caspase-1 inhibitor YVAD was purchased from Alexis Bio-
chemicals (San Diego, CA, USA), reconstituted in 10 mmol/L DMSO, and
subsequently diluted to the desired concentration in medium (RPMI
1640). Syk inhibitor was purchased from Calbiochem (San Diego, CA,
USA). In experiments using pharmacological inhibitors, control cells were
treated with an equivalent concentration of vehicle (0.01–0.1% DMSO).
Synthetic Pam3Cys4 (TLR2 agonist) was purchased from EMC Microcollec-
tions (Germany), and the production of highly purified, particulate -glu-
can has been described elsewhere [12].
Candida strains
UC820 was used in the experiments, unless otherwise indicated. The efg1/
cph1 transcription factor double-knockout strain was a kind gift from Dr.
Gerald. Fink(Whitehead Institute, Cambridge, MA, USA). CAI-4 strain is the
parental strain of the mutants used in this study. The och1 and och1 
OCH1-complemented strains have been characterized previously [13]. The
hgc1 hyphae-deficient mutant and hgc1 HGC1-complemented strains
were kindly provided by Dr. Yue Wang (Institute of Molecular and Cell Bi-
ology, Singapore) [14]. Bwp17, the eed1 and eed1  EED1-complemented
strains were kindly provided by Dr. Benhard Hube (Hans Knöll Institute,
Jena, Germany). C. albicans was grown overnight in Sabouraud broth at
25°C, and cells were thereafter harvested by centrifugation, washed twice,
and resuspended in culture medium (RPMI 1640; ICN Biomedicals, Au-
rora, OH, USA). C. albicans was killed for 1 h at 100°C or by treatment
with 0.04% thimerosal overnight. The killed C. albicans cells were washed
three times with PBS and resuspended in culture medium for macrophage
stimulation and cytokine induction.
Patients and donors
Peripheral blood was taken from healthy individuals, three patients with CMC,
four patients with HIES, and two patients with Y238X dectin-1 mutation with mu-
cocutaneous fungal infection under Institutional Review Board approval of Rad-
boud University Nijmegen Medical Center (Nijmegen, The Netherlands).
Monocyte-derived macrophages
Separation and stimulation of human monocytes or macrophages were per-
formed as described elsewhere [15]. Human monocytes were cultured in
complete RPMI-1640 medium (ICN Biomedicals) supplemented with 100
ng/ml human M-CSF and 10% pooled human serum for 6 days. Cocultures
of monocytes or macrophages with lymphocytes were performed for the
induction of IL-17 production.
PBMC and macrophage stimulation
A sample of 5  105 PBMCs/well (or 5104 macrophages/well) was
seeded in 96-well plates and stimulated with 1  105/ml live or 1  106/ml
heat-killed C. albicans yeast cells (final volume of 200 l/well) in RPMI.
Supernatant was collected after 24 h (for TNF, IL-6, and IL-1 measure-
ment) or 7 days (for IL-17 and IL-22 measurement).
Cytokine measurements
IL-6, TNF, IL-1, IL-17, and IL-22 concentrations were measured by com-
mercial sandwich ELISA kits (R&D Systems, The Netherlands), according
to the manufacturer's instructions. For intracellular IL-1 measurement,
after collecting of supernatant for extracellular cytokine measurement, 200
l fresh RPMI was added to the macrophage. Then, the plate was put into
a –80°C freezer, rapidly freezing and thawed at room temperature. This
freeze-thaw cycle was repeated three times. Intracellular IL-1 was deter-
mined by ELISA.
Intracellular cytokine staining
PBMCs were stimulated for 4–6 h with PMA (50 ng/ml; Sigma-Aldrich, St.
Louis, MO, USA) and ionomycine (1 mg/ml) (Sigma-Aldrich) in the pres-
ence of GolgiPlug (BD Biosciences, San Jose, CA, USA), according to the
manufacturer's protocols. Cells were first stained using an anti-CD4 APC
antibody (BD Biosciences). Subsequently, the cells were fixed and perme-
abilized with Cytofix/Cytoperm solution (BD Biosciences) and then stained
with anti-IFN- PE (eBioscience, San Diego, CA, USA) and anti-IL-17 FITC
(eBioscience). Samples were measured on a FACSCalibur, and data were
analyzed using the CellQuest Pro software (BD Biosciences).
Cell-wall porosity measurement
The porosity of the cell walls of exponential-phase yeast cells grown in
RPMI and hyphae grown in 2.5% (v/v) serum at 37°C for 4 h was com-
pared. This assay is based on the ability of polycationic polymers
(DEAE-dextran and PLL) to enhance the permeability of the cell mem-
brane, resulting in release of UV-absorbing compounds measured at 260
nm [16].
Freeze-substitution TEM
C. albicans hyphal cells were grown in 20% (v/v) serum with 50 g/ml uri-
dine supplementation for 3 h. Samples were collected by centrifugation
and immobilized immediately by high-pressure freezing with a Leica EM
PACT2 (Leica Microsystems UK, Milton Keynes, UK). After freezing, cells
were freeze-substituted in substitution reagent (1% OsO4/0.1% uranyl ace-
tate in acetone) with a Leica EM AFS2. Ultrathin sections were prepared
with a Diatome diamond knife on a Leica UC6 ultramicrotome, stained
with uranyl acetate and lead citrate, and examined in a Philips CM10 trans-
mission microscope (FEI UK, Cambridge, UK).
Caspase-1 activity measurement
Caspase-1 activity was determined by a caspase-1 fluorometric assay kit (Bio-
Vision, Mountain View, CA, USA), according to the manufacturer’s instruc-
tion. Briefly, 2  106 macrophages were stimulated with C. albicans UC820
or efg1/cph1 strain for 6 h and lysed with cell lysis buffer on ice for 10
min. Then, equal volumes of 2 reaction buffer and YVAD-7-amino-4-trif-
luoromethylcoumarin were added to the cell lysate within a 96-well plate at
37°C, and the emitted fluorescence was read by FLUOstar Optima micro-
plate (BMG Labtech, Cary, NC, USA) at 90-s intervals for 200 cycles using
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400 nm excitation and 505 nm emission filters. The relative activity was cal-
culated compared with recombinant caspase-1 enzymatic activity.
RESULTS
The Th17 pathway is compromised in patients with
mucosal candidiasis
Our first step was to define the main components of the mu-
cosal antifungal host defense mechanism that were responsible
for the elimination of the fungus once invasion occurred. To
identify this mechanism, individuals with specific inborn de-
fects of mucosal-antifungal immunity were studied, such as
HIES [6] and CMC patients [5]. We first assessed the innate
host response triggered in PBMCs of CMC patients by C. albi-
cans. Production of monocyte-derived proinflammatory cyto-
kines, such as TNF and IL-6, was normal (Fig. 1A). Similar re-
sults were found in HIES patients (data not shown). In con-
trast, T cells isolated from CMC and HIES patients secreted
Figure 1. CMC and HIES patients
have defective IL-17 production
upon C. albicans stimulation.
(A) PBMCs from CMC patients
(n3), consisting of a coculture of
monocytes and lymphocytes, and
healthy controls were stimulated
with heat-killed C. albicans for 24 h.
Supernatant was harvested, and TNF
and IL-6 concentration was deter-
mined by ELISA (n6, *P0.05).
(B) PBMCs from CMC (n3) and
HIES (n4) patients and healthy
control were stimulated with heat-
killed C. albicans for 7 days. Superna-
tant was harvested, and IL-17 and
IL-22 concentration was determined
by ELISA. (C) Intracellular cytokine
staining of IL-17 and IFN- in hu-
man PBMCs stimulated for 5 days
with RPMI or C. albicans and then
stimulated for 4 h with PMA and
ionomycin. Cells were gated for
CD4. Representative data from two
separate experiments with a total
n  3 are shown here.
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significantly less IL-17 in response to C. albicans stimulation
than those of healthy controls, as shown by secreted IL-17-,
IL-22 (Fig. 1B)-, and IL-17-positive T cells (Fig. 1C). These re-
sults are supported by the previous reports that CMC [5] and
HIES [6] patients failed to induce protective IL-17 production
in response to C. albicans stimulation. Th17 responses seem
therefore to be one of the main components of the mucosal
antifungal defense mechanism.
C. albicans germ-tube formation is critical for
stimulation of IL-1 production in macrophages
As the transformation of Candida yeasts into hyphae is a cru-
cial step in tissue invasion, we hypothesized that differential
recognition of colonizing yeasts and invasive hyphae by macro-
phages may induce distinct cytokine profiles that may be in-
ductive or not for Th17 responses. IL-1 and IL-6 are the two
main cytokines required for the initiation of Th17 responses
[7], and IL-23 is important for the proliferation of Th17 cells
[17]. To test this hypothesis, we stimulated human macro-
phages derived from monocytes in culture with a yeast-locked
efg1/cph1 transcription factor double-knockout C. albicans
strain, which is unable to form hyphae [18] (mimicking colo-
nization), and its corresponding WT strain, which forms germ
tubes in culture (mimicking tissue invasion). IL-6 stimulation
did not differ between germ-tube-positive and germ-tube-nega-
tive strains. However, the hyphae-forming WT strain induced
strong IL-1 responses, whereas the yeast-locked efg1/cph1
C. albicans strain was completely unable to stimulate produc-
tion of IL-1 (Fig. 2A). TNF production induced by the
efg1/cph1 strain was also slightly lower, most likely as a
result of endogenous, IL-1-induced TNF. In contrast, live
Candida strains induced a comparable amount of IL-1 in
Figure 2. Macrophage responds specifically to C.
albicans hyphae and induces IL-1. (A) Monocyte-
derived macrophages and (B) PBMCs were stimu-
lated with live C. albicans UC820 or a efg1/cph1
hyphae-negative mutant for 24 h. (C) Monocyte-
derived macrophages were stimulated with
UC820, hgc1, and its complemented control
strain for 24 h. Supernatant was harvested, and
IL-1 and IL-6 concentration was determined by
ELISA (n6; *P0.05).
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monocytes (Fig. 2B). To exclude the possibility that the de-
fective IL-1 production was a pleiotropic consequence of
the efg1/cph1 genetic background, we also examined the
C. albicans strain hgc1 [14], which is also unable to form
germ tubes, and the eed1 mutant, which was unable to sus-
tain hyphal growth [19]. The relevant, complemented con-
trol strains were also tested for their capacity to induce pro-
duction of IL-1 in macrophages. Similar results were ob-
served as with the efg1/cph1strain (Fig. 2C and
Supplemental Fig. 1). These data suggest strongly that in-
duction of IL-1 production delineates the level at which
the immune system discriminates the colonization and inva-
sive forms of C. albicans and suggest that the capacity to
form and sustain hyphal growth is a requirement for a vig-
orous IL-1 response.
C. albicans hyphae induction of IL-1 secretion is
dependent on caspase-1 activity
IL-1 production is regulated at multiple levels: mRNA tran-
scription, translation into inactive pro-IL-1, and activation of
the protein platform called the inflammasome, which results
in caspase-1 activation and processing of the procytokine into
the mature, active IL-1 [20]. First, we investigated whether
this difference in IL-1 induction by yeast and hyphal cells is
caused by the differential activation of transcription or pro-
IL-1 synthesis. IL-1 mRNA expression did not differ when
cells were stimulated with the WT or the efg1/cph1 mutant
(Fig. 3A), indicating that transcription is equally induced by
yeasts and hyphae. Moreover, WT and the efg1/cph1 mutant
induced similar concentrations of intracellular pro-IL-1 (Fig.
Figure 3. C. albicans hyphae specifically activate inflam-
masome in macrophage. (A) Monocyte-derived macro-
phages were stimulated with live C. albicans UC820 or
the efg1/cph1 mutant for 6 h, and then total mRNA
was harvested for RT-PCR. IL-1 expression levels were
normalized with -2-microglobulin and show as fold of
relative expression (n6). (B) Monocyte-derived mac-
rophage was stimulated with live C. albicans UC820 or
the efg1/cph1 mutant strain for 3 h, and then intra-
cellular pro-IL-1 was harvested. The concentration
was determined by ELISA (n6). (C) Monocyte-de-
rived macrophages were stimulated with live C. albicans
UC820 for 24 h in the presence of DMSO or caspase-1
inhibitor, respectively. Supernatant was harvested. The
concentration of IL-1 and TNF was determined by ELISA (n8; *P0.05). (D) Caspase-1 activity was in-
duced by C. albicans UC820 but not by the hyphae-deficient efg1/cph1 mutant. Cells were stimulated with
the two different C. albicans strains for 6 h, and the caspase-1 activity was measured in the cell lysate for a
duration of 5 h. Each dot represents the measured value of the fluorescence intensity with the interval of
60 s between each dot. Representative data from two separate experiments were shown here.
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3B), indicating that the subsequent translation of pro-IL-1 is
not affected. We further investigated whether differential in-
flammasome activation could be the cause of the difference in
IL-1 secretion. Blocking caspase-1 activity with a specific in-
hibitor led to inhibition of IL-1 secretion induced by WT C.
albicans, indicating that active caspase-1 is required for IL-1
secretion (Fig. 3C). Monocytes express activated caspase-1 con-
stitutively, and this explains the IL-1 induction by yeasts and
hyphae in monocytes. In contrast, macrophages lack a consti-
tutively active caspase-1 [21], providing a target for differential
activation by yeast cells and hyphae. Indeed, only the hyphae-
competent WT strain, and not the efg1/cph1 C. albicans
strain, was able to activate caspase-1, indicating that hyphae
formation is important for macrophage inflammasome activa-
tion and IL-1 secretion (Fig. 3D).
Hyphal PAMPs are crucial in the induction of
inflammasome activation
Next, we investigated the recognition mechanism responsible
for the capacity of the macrophage to distinguish C. albicans
hyphae from yeast, leading to IL-1 secretion. Recognition of
fungal PAMPs by specific PRRs is responsible for the innate
immunity stimulation [22]. We manipulated the profile of
PAMPs exposed by the C. albicans yeasts and hyphae by heat-
Figure 4. Exposure of PAMPs situ-
ated underneath the mannan layer
in hyphae is responsible for IL-1
production. (A) Monocyte-derived
macrophages were stimulated with
heat-killed (HK) C. albicans yeast
or hyphae for 24 h. Supernatant
was harvested, and the concentra-
tion of IL-1 and TNF was deter-
mined by ELISA. (B) Monocyte-
derived macrophages were stimulated
with heat-killed or thimerosal-treated
C. albicans yeast for 24 h. Superna-
tant was harvested, and the con-
centration of IL-1 and TNF was
determined by ELISA. (C) The
porosity of two C. albicans strains,
CAF-2 and UC820, was measured
by the relative sensitivity to PLL
and DEAE-dextran sensitivity.
(D) TEM of yeasts and hyphae (ar-
rowheads indicate mannan fibrils).
(E) Average mannan fribril length
from 30 randomly selected C. albi-
cans yeast and hyphae. (F) Mono-
cyte-derived macrophage was stim-
ulated with heat-killed CAI-4, the
och1 N-mannan glycosylation mu-
tant, and its complemented con-
trol strain, respectively, for 24 h.
Supernatant was harvested, and
the concentration of IL-1 was de-
termined by ELISA (n6;
*P0.05).
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killing, which is known to expose inner cell-wall components
such as -glucans and chitin [23]. In contrast, thimerosal fixa-
tion kills cells while preserving the native cell-wall architecture.
Interestingly, heat-killed yeast induced IL-1 production, simi-
larly to heat-killed hyphae (Fig. 4A). In contrast, thimerosal-
killed C. albicans induced very little IL-1 (Fig. 4B), and heat
treatment of thimerosal-killed C. albicans restored the IL-1-
inducing ability (not shown). This suggests that recognition of
inner cell-wall PAMPs of yeast cells can also lead to IL-1 se-
cretion.
Based on these findings, we hypothesized that the differen-
tial ability of C. albicans yeast and hyphae to activate the in-
flammasome was a result of differences in the profile of
PAMPs expressed in the yeast and hyphal cell walls and that
this difference was most likely to be a result of differences in
the components of the inner cell-wall layer that are known to
be exposed during invasion of the tissue by C. albicans hyphae
[24]. Hypothetically, differences in porosity of the cell wall
between yeasts and hyphae could facilitate the recognition of
the inner hyphal cell-wall layers by PRRs. However, this proved
not to be the case, as measurements of porosity of the cell wall
demonstrated that hyphal wall porosity was less than that of
the yeast cell wall (Fig. 4C). We therefore assessed the capacity
of individual cell-wall components to induce IL-1. Mannopro-
teins constitute the major component of the outer cell wall of
both forms, but the rapid growth of hyphae, which does not
allow the complex branching of mannans, is hypothesized to
result in significant structural differences in mannans of yeasts
and hyphae (Fig. 4D). Indeed, TEM analyses showed that the
outer-wall mannan fringe length was longer in mother cell
(yeast) than in hyphae (0.1160.014 m vs. 0.0730.013 m;
Fig. 4E). The och-1 C. albicans glycosylation mutant lacks most
of the branched outer-wall N-mannan fibrils [15]. We there-
fore compared IL-1 production by macrophages stimulated
with heat-killed CAI-4 (parental strain) with the och1 null mu-
tant and its cognate OCH1-complemented strain. Interestingly,
IL-1 production was significantly greater when macrophages
are stimulated with the och-1 C. albicans strain compared with
the isogenic parental strain and the complemented control
strain (Fig. 4F). Therefore, short mannan fibrils, which permit
“tasting” of the C. albicans PAMPs of the inner cell wall, are
associated with induction of IL-1 production by macrophages.
Dectin-1 is partially responsible for the C. albicans-
induced IL-1 production
The C-type lectin receptors, dectin-1 and dectin-2, recognize
the C. albicans -glucans and -mannans, respectively, and
both signal through Syk kinase [25, 26]. A pharmacological
Syk inhibitor partially inhibited C. albicans-induced IL-1 secre-
tion in cells from healthy volunteers (Fig. 5A), suggesting a
role of a Syk-coupled receptor in IL-1 secretion. Macro-
phages isolated from patients homozygous for the early stop
codon mutation Tyr238X in dectin-1, which completely lacks
functional dectin-1 expression [27], were exposed to C. albi-
cans in the presence or absence of the Syk inhibitor or a
caspase-1 inhibitor. Macrophages from dectin-1 Tyr238X pa-
Figure 5. Production of IL-1 in dectin-1-depen-
dent and -independent pathways in response to
C. albicans stimulation. (A) Monocyte-derived
macrophage from normal dectin-1 controls or
dectin-1 Y238X patients was stimulated with live
C. albicans UC820 for 24 h in the presence of
DMSO (open bars) or Syk inhibitor (closed
bars). Supernatant was harvested, and the con-
centration of IL-1 was determined by ELISA
(dectin-1 control, n8; dectin-1 Y238X, n2,
*P0.05). (B) Monocyte-derived macrophages
from healthy volunteers and dectin-1 Y238X pa-
tients were stimulated with -glucans (10 g/
ml), alone or in combination with Pam3Cys4 (1
g/ml) for 24 h. Supernatant was harvested, and the concentration of IL-1 was determined by ELISA (dectin-1 control, n3; dectin-1 Y238X,
n2). (C) Monocyte-derived macrophages from dectin-1 Y238X patients were stimulated with live C. albicans UC820 for 24 h in the presence of
DMSO and caspase-1 inhibitor. Supernatant was harvested, and the concentration of IL-1 was determined by ELISA. (D) Monocyte-derived mac-
rophages were stimulated with live C. albicans UC820 in the presence of autologous lymphocytes, in the presence or absence of IL-1Ra for 7 days.
Supernatant was harvested, and the concentration of IL-17 was determined by ELISA. (E) Monocyte-derived macrophages were stimulated with
live C. albicans UC820 of the efg1/cph1 strain in the presence of autologous lymphocytes, in the presence or absence of IL-1Ra for 7 days. Super-
natant was harvested, and the concentration of IL-17 was determined by ELISA.
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tients released significantly less IL-1 than macrophages from
healthy individuals when challenged with C. albicans cells (Fig.
5A). Moreover, unlike the macrophage from healthy individu-
als, macrophage from dectin-1 Tyr238X patients was not af-
fected by the Syk inhibitor, underlining the putative role of
the dectin-1/Syk pathway for induction of IL-1 by macro-
phages (Fig. 5A). This conclusion was further supported by
experiments showing the stimulation of IL-1 by purified
-glucans, which is an entirely dectin-1-dependent mechanism
(Fig. 5B). However, at least one additional pathway must be
responsible for IL-1 induction in macrophages, as residual
IL-1 production was consistently observed in macrophages
defective for dectin-1 expression. Recognition of mannans by
mannose receptor [15] or dectin-2 [26] was not responsible
for this residual production. This was confirmed by small inter-
fering RNA-directed knockdown of expression of these recep-
tors, which failed to show any effect on IL-1 production (not
shown). Although chitin is an important candidate for residual
IL-1 production, and the chitin-enriched och1 strain led to
increased IL-1 production (Fig. 4F), the unknown nature of
the PRR for chitin prevented us from exploring the hypothesis
that this residual pathway is related to the recognition of cell-
wall chitin. This second, minor pathway of IL-1 stimulation
was also shown to be inflammasome-dependent, as a caspase-1
inhibitor also reduced IL-1 production in cells isolated from
dectin-1-deficient patients (Fig. 5C).
IL-1 induced by C. albicans hyphae leads to IL-17
production
IL-1 has been demonstrated to be critical for Th17 differenti-
ation in humans [7], and blocking the IL-1RI signaling path-
way by IL-1Ra inhibited the induction of IL-17 induced by C.
albicans (Fig. 5D). We assessed whether the differences in
IL-1 induction by yeasts and hyphae also lead to differences
in Th17 responses. Indeed, the yeast-locked efg1/cph1 C.
albicans mutant failed to induce IL-17 in macrophages that
were cocultured with T cells, whereas hyphae-forming WT C.
albicans induced Th17 differentiation and IL-17 production
(Fig. 5E). These results demonstrate that the induction of
IL-1 by the macrophage is critical for Th17 differentiation,
and the phenotypic switch between yeasts and hyphae deter-
mines the triggering of a Th17 response.
DISCUSSION
Much attention has been devoted to the understanding of how
the immune system defends the host from fungal infection. Th1
and Th17 responses have been shown to have beneficial effects
for the host defense against C. albicans infection [4, 28]. How-
ever, the mechanisms of discrimination between C. albicans colo-
nization and invasion are still poorly understood. A recent study
has described colonizing yeasts and invading hyphae, causing dif-
ferential activation of the c-Jun and c-Fos transcription factors in
epithelial cells [2]. The discriminatory mechanisms operating at
the level of the immune response are unknown. In the present
study, we report that antifungal defense depends on mounting an
efficient Th17 response. This is the major immune defect in pa-
tients with chronic mucosal fungal infections such as CMC and
HIES, which share Th17 defects [5, 6]. The protective anti-C. albi-
cans Th17 response is initiated when C. albicans forms germ
tubes, which are recognized by macrophages via a dectin-1/Syk-
dependent mechanism. The hyphae-induced, protective Th17
differentiation is dependent on inflammasome activation and
IL-1 production.
In the CMC patients, we observed defective production of
IL-17 and a partial defective IFN- production but no differ-
ence in IL-6, TNF, and IL-1 production. The importance of
Th17 responses for antifungal host defense is supported by
two additional lines of evidence: IL-17 is important for host
defense against systemic fungal infection [29, 30], and IL-17
has been shown to be a crucial component of mucosal antifun-
gal defense in a murine experimental model [4]. Th17 re-
sponses are initiated by two signals: presentation of a fungal
antigen in the context of the activation by costimulatory mole-
cules and the release of an appropriate cytokine milieu by the
APCs, such as tissue macrophages [22]. IL-1 production is
essential for mounting an effective Th17 response, and this is
dependent on the processing of the inactive pro-IL-1 into
active IL-1 by the inflammasome and caspase-1 activation.
Efg1 and Cph1 are two important transcription factors that
regulate C. albicans yeast to hyphae morphogenesis [30]. The
efg1/cph1 double-knockout C. albicans strain is unable to
form hyphae, even when grown in strong hyphae-inducing cul-
ture conditions [31]. It has been also shown that efg1/cph1
is avirulent in the mouse model [31], demonstrating that hy-
phae formation is critical for C. albicans invasion. In addition,
from the point of view of the clinical histology of mucosal can-
didiasis patients, germ-tube formation in serum is a much-used
clinical diagnostic test. By stimulating macrophage with WT
and efg1/cph1 C. albicans strains, we showed that hyphae de-
velopment during tissue invasion is crucial for macrophage
recognition and IL-1 production via inflammasome activa-
tion. Similarly, macrophages stimulated with hgc1 and eed1
strains, which are unable to form [14] or to sustain hyphal
growth [19], produced significantly lower IL-1, demonstrat-
ing that sustained hyphal development is required for effective
inflammasome activation and IL-1 production. This was not a
result of alterations in the host transcription of the IL-1 gene
but rather, a hyphae-specific induction of inflammasome acti-
vation in the macrophage. In contrast, the WT and the yeast-
locked C. albicans strains induced IL-1 production in blood
monocytes, which are cells that are present in the normally
sterile bloodstream, where presence of yeast or hyphal cells is
indicative of invasion. The production of IL-1 by monocytes
stimulated with yeasts and hyphae is a result of the constitu-
tively active caspase-1 in these circulating monocytes [21].
These data indicate that the macrophage is the key cell type
recognizing the invading C. albicans in tissues. Similar mecha-
nisms could also be present in DCs, which also lack a constitu-
tively active caspase-1 [21].
Reinforcing these observations in human cells, Joly and col-
leagues [32] showed earlier that hyphal formation triggers Nlrp3
inflammasome activation in murine macrophages. However,
there may be intrinsic differences between murine and human
macrophages in terms of hyphal recognition and inflammasome
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activation. In contrast to human macrophages, in which hyphae
induce IL-1 transcription and inflammasome activation, the prim-
ing of murine macrophage with LPS is a prerequisite for effective
IL-1 production by fungal hyphae. This implies that in mice hy-
phae, formation triggers Nlrp3 inflammasome activation but not
pro-IL-1 translation. As LPS by itself could only induce pro-IL-1
translation in macrophages, no active IL-1 could be released with-
out the activation of inflammasome [21]. Nevertheless, the finding
by Joly et al. [32] laid the foundation to explore the role of hyphal
germination and inflammasome activation in human macrophages.
We also addressed the question as to why only hyphae, but
not yeasts, induced inflammasome activation in human macro-
phages. An important difference between these fungal cell
types was noted in terms of the length of the mannan fibrils in
yeasts and hyphae. The length of these fibrils is shorter, and
mannans may be less branched on the hyphal cell wall. This
could make the inner PAMPs more easily accessible for macro-
phage PRRs. To test this hypothesis, we stimulated macro-
phages with the glycosylation defection och1 C. albicans strain,
which lacks highly branched outer-chain mannans. The och1
C. albicans strain induced a stronger stimulation of IL-1 secre-
tion. From these findings, we conclude that although the man-
nan fibrils may not be responsible for the induction of IL-1,
the absence of a fully matured, branched outer-mannan layer
permits the enhanced recognition of inner structures of the C.
albicans cell wall, which in turn induces IL-1 production.
The loss of branched mannans in the och1 C. albicans
strain results in the activation of cell-wall biosynthetic path-
ways, which result in higher relative amounts of -glucans
(88.3% vs. 59.5% in WT) and chitin (1.8% vs. 1.0% in WT)
[13]. This suggests that the enhanced recognition of these
fungal components by specific PRRs, such as the dectin-1/Syk
pathway for the recognition of -glucans, may be responsible
for the augmented production of IL-1. To test this, we per-
formed a set of experiments using Syk inhibitors and cells iso-
lated from patients with a dectin-1 deficiency [27]. We ob-
served that the dectin-1/Syk pathway was partly responsible for
the induction of IL-1. A possible secondary mechanism could
involve the recognition of chitin by an as-yet-unknown recep-
tor. These data are supported by a recent in vitro study impli-
cating the -glucan recognition pathway by dectin-1 for the
activation of the inflammasome [33].
Colonization by C. albicans yeasts is tolerated by the host de-
fense system and does not elicit a strong inflammatory reaction.
However, during conversion of C. albicans yeasts to hyphae and
tissue invasion, inflammasome activation leads to caspase-1 activa-
tion and IL-1 secretion, which is instrumental in inducting a
protective Th17 response (Fig. 5E). The dectin-1/Syk pathway
appears therefore to act as a master regulator of the differential
recognition of colonizing yeasts versus invading hyphae, mainly
through the activation of the IL-1/Th17 pathway.
The model proposed in this study is based on experiments in
human cells, but it is supported by murine studies. Mouse macro-
phages activate the inflammasome in response to hyphal compo-
nents [32], whereas mice defective in inflammasome components
[10, 11] or IL-17Rs [4] are highly susceptible to systemic or oro-
pharyngeal candidiasis. In addition, a critical role of macrophages
in mucosal immunity has been shown in clearing primary and
secondary pneumococcal colonization in a Th17-dependent man-
ner [34]. Here, we propose that in addition to their role in con-
trolling bacterial colonization, macrophages discriminate coloni-
zation from invasion during C. albicans infection.
In conclusion, in this study, we demonstrate that the im-
mune mechanism responsible for the activation of antifungal
defense during tissue invasion by C. albicans hyphae is the IL-
1-driven Th17 response. The differential induction of Th17
responses by colonizing yeasts (no induction) and invading
hyphae (potent induction of Th17) represents one of the
main immune mechanisms discriminating between C. albicans
colonization and invasion states. The mechanisms behind this
process are complex: (i) conversion from yeast cells into hy-
phae is essential for Th17 induction; (ii) inflammasome activa-
tion associated with hyphae formation is the discriminating
step during production of IL-1 and the subsequent IL-17 in-
duction; (iii) dectin-1/Syk recognition of -glucans is an essen-
tial component of inflammasome activation and IL-1 release
(this step is defective in patients with dectin-1 deficiency); and
(iv) differences in the mannan architecture in yeast and hy-
phal cells may result in the recognition of inner cell-wall com-
ponents such as -glucans in hyphae. This is supported by the
observation that glycosylation-defective C. albicans strains in-
duce higher IL-1 production by macrophages.
These findings have important conceptual and practical conse-
quences. First, they describe one of the likely mechanisms re-
sponsible for discriminating between benign colonization and
harmful invasion by C. albicans. The proper discrimination of
these two states is crucial for avoiding inappropriate inflamma-
tion of colonized mucosal surfaces, while retaining a vigorous
inflammatory response to cells that penetrate beyond the most
superficial layers of the mucosa. Second, this model of tissue rec-
ognition of invasion is likely to be important for other colonizing
microorganisms: in case of bacteria, the second signal needed to
trigger inflammasome activation may be the release of ATP from
dead cells during tissue invasion [21]. Our model suggests that
during nonsymptomatic carriage of C. albicans in nondiseased
individuals, an equilibrium may be established in which commen-
sal carriage of yeast cells is sustained by successful Th17-depen-
dent elimination of opportunistic infiltration of hyphae in the
outer mucosal layers. When the normal microbiological or immu-
nological balance at the mucosal surface is perturbed, increases
in the numbers of invading hyphae may then represent the trig-
ger for a vigorous inflammatory defense. Future validation of
these findings in a mucosal candidiasis experimental model, as-
sessing in vivo the role of the dectin-1/Syk/inflammasome path-
way for IL-17 production, will be of great importance to comple-
ment the in vitro findings reported here.
Finally, our findings provide important clues about the
mechanisms through which tolerance may be lost during in-
flammatory bowel disease: it is important to note that in
Crohn’s disease, specific anti-C. albicans antibodies have been
described [35]; genetic variants in the inflammasome compo-
nent NLRP3 predispose to disease [36]; and C. albicans exacer-
bates colitis in mice [37]. This study provides clues about the
mechanisms that may have contributed to a defective anti-C.
albicans response in the intestinal mucosa of these patients and
may offer a new therapeutic approach to this disease.
Cheng et al. Discrimination of mucosal C. albicans invasion
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